These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 26361912)

  • 1. The Unspoken Shift From Quality to Quantity Standards In Substance Use(r) Treatment and Prevention: A Challenge to Unfinished Intervention Business.
    Israelashvili M
    Subst Use Misuse; 2015; 50(8-9):1079-82. PubMed ID: 26361912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Success, Failure, and Unfinished Business of Education, Prevention, Policy, and Intervention Programs on Substance Misuse in Brazilian Sport.
    Santos AM
    Subst Use Misuse; 2015; 50(8-9):1139-43. PubMed ID: 26361918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-Informed, Evidence not Used: A Pilot Study of a Sustained Flawed Process and Unfinished Business.
    Einstein SS; Straussner SL; Johnson TP; Gartside W
    Subst Use Misuse; 2015; 50(8-9):1216-9. PubMed ID: 26361929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling, Modeling, Consensus, and Substance Use(r) Policy Intervention: Unfinished Business.
    Ferguson B
    Subst Use Misuse; 2015; 50(8-9):1125-30. PubMed ID: 26361915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of relapse prevention for substance users: treatment settings and health care policy.
    Yamada T; Chen CC; Yamada T
    Adv Health Econ Health Serv Res; 2005; 16():431-50. PubMed ID: 17867251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a positive youth development program in urban after-school settings on the prevention of adolescent substance use.
    Tebes JK; Feinn R; Vanderploeg JJ; Chinman MJ; Shepard J; Brabham T; Genovese M; Connell C
    J Adolesc Health; 2007 Sep; 41(3):239-47. PubMed ID: 17707293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of ''No Child Left Behind'' legislation on drug prevention in US Schools.
    Cho H; Dion Hallfors D; Iritani BJ; Hartman S
    Eval Rev; 2009 Oct; 33(5):446-63. PubMed ID: 19429841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future directions in elementary school drug prevention.
    Hansen WB
    J Drug Educ; 2010; 40(1):91-8. PubMed ID: 21038766
    [No Abstract]   [Full Text] [Related]  

  • 9. Measuring Substance Use and Misuse via Survey Research: Unfinished Business.
    Johnson TP
    Subst Use Misuse; 2015; 50(8-9):1134-8. PubMed ID: 26361917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New systems of care for substance use disorders: treatment, finance, and technology under health care reform.
    Pating DR; Miller MM; Goplerud E; Martin J; Ziedonis DM
    Psychiatr Clin North Am; 2012 Jun; 35(2):327-56. PubMed ID: 22640759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating evidence-based practices into policy: a case study in Texas.
    Cochran G; Montgomery KL; Bell H
    Soc Work Health Care; 2012; 51(5):383-401. PubMed ID: 22583026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priorities for policy research on treatments for alcohol and drug use disorders.
    McCarty D; McConnell KJ; Schmidt LA
    J Subst Abuse Treat; 2010 Sep; 39(2):87-95. PubMed ID: 20598828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of schools in substance use prevention and intervention.
    Benningfield MM; Riggs P; Stephan SH
    Child Adolesc Psychiatr Clin N Am; 2015 Apr; 24(2):291-303. PubMed ID: 25773325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A large-scale initiative to disseminate an evidence-based drug abuse prevention program in Italy: Lessons learned for practitioners and researchers.
    Velasco V; Griffin KW; Antichi M; Celata C
    Eval Program Plann; 2015 Oct; 52():27-38. PubMed ID: 25913236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance use prevention for adolescents: the Icelandic Model.
    Sigfúsdóttir ID; Thorlindsson T; Kristjánsson AL; Roe KM; Allegrante JP
    Health Promot Int; 2009 Mar; 24(1):16-25. PubMed ID: 19074445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is universal prevention against youths' substance misuse really universal? Gender-specific effects in the EU-Dap school-based prevention trial.
    Vigna-Taglianti F; Vadrucci S; Faggiano F; Burkhart G; Siliquini R; Galanti MR;
    J Epidemiol Community Health; 2009 Sep; 63(9):722-8. PubMed ID: 19395396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescent substance use disorders in the school setting.
    Yule AM; Prince JB
    Child Adolesc Psychiatr Clin N Am; 2012 Jan; 21(1):175-86, xi. PubMed ID: 22137820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance misuse prevention and economic analysis: challenges and opportunities regarding international utility.
    Guyll M; Spoth R; Cornish MA
    Subst Use Misuse; 2012; 47(8-9):877-88. PubMed ID: 22676560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based programs in school settings: barriers and recent advances.
    Powers JD; Bowen NK; Bowen GL
    J Evid Based Soc Work; 2010 Jul; 7(4):313-31. PubMed ID: 20799130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug prevention programmes for young people: where have we been and where should we be going?
    Midford R
    Addiction; 2010 Oct; 105(10):1688-95. PubMed ID: 20039859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.